Wnt/beta-catenin signaling pathway in leukemia (WP3658)
The Wnt/Beta-catenin pathway mediates the transcription of proteins important for maintenance and growth of hematopoietic stem cells. The inhibition of Wnt leads to protein degradation through Beta-Catenin activation by the Axin/APC/CK1/GSK3B protein complex. This pathway is based on figure 5 from Misaghian et al. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP3658 CPTAC Assay Portal]
Authors
AAR&Co , Linda Rieswijk , Kristina Hanspers , Mick Eikelhof , Andika Tan , Maintenance bot , and Eric WeitzCited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organism
Homo sapiensCommunities
CPTAC DiseasesAnnotations
Disease Ontology: leukemia
Pathway Ontology: altered Wnt signaling pathway
Participants
References
- Misaghian N, Ligresti G, Steelman LS, Bertrand FE, Bäsecke J, Libra M, et al. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia. 2009 Jan;23(1):25–42. PubMed Europe PMC Scholia